Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Windsor

$6,240.00

Enantioselective catalyis and total synthesis of alkaloids

FY 2010-11

Summary
We are developing new methods for the synthesis of chiral compounds. Chiral compounds are extremely important to both the pharmaceutical and fine chemical industries. For example, worldwide sales of chiral drugs are well over a hundred billion dollars. The first half of proposed NSERC-funded research focuses on the development of new classes of chiral catalysts. The discovery of better catalysts is crucial to improving the ways in which the afore-mentioned compounds can be made. Ultimately, our research, if proven successful, might be able to lower the cost of manufacturing human pharmaceuticals and other important chemicals. The second half of our NSERC proposal delineates a new synthetic route to a class of molecules that exhibit very promising therapeutic properties in humans. Research in this field might one day lead to the development of better medicines for the treatment of serious ailments. The NSERC grant also enables the training of highly qualified chemists that are required in the pharmaceutical and other allied chemical industries.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
311670-2008
Name nom
Thadani, Avinash
Department département
Chemistry and Biochemistry
Organization id
37
Institution établissement
University of Windsor
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2008
Award amount
6240
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
3
Nb partie
3
Application title
Enantioselective catalyis and total synthesis of alkaloids
Keyword
NSERC
Application summary
We are developing new methods for the synthesis of chiral compounds. Chiral compounds are extremely important to both the pharmaceutical and fine chemical industries. For example, worldwide sales of chiral drugs are well over a hundred billion dollars. The first half of proposed NSERC-funded research focuses on the development of new classes of chiral catalysts. The discovery of better catalysts is crucial to improving the ways in which the afore-mentioned compounds can be made. Ultimately, our research, if proven successful, might be able to lower the cost of manufacturing human pharmaceuticals and other important chemicals. The second half of our NSERC proposal delineates a new synthetic route to a class of molecules that exhibit very promising therapeutic properties in humans. Research in this field might one day lead to the development of better medicines for the treatment of serious ailments. The NSERC grant also enables the training of highly qualified chemists that are required in the pharmaceutical and other allied chemical industries.